Catalyst Wire Dossier Catalyst Wire Dossier

ABELADRUG200

· Abela Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABELADRUG200, covering 2010-12-08 to 2010-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury [Phase 1, Phase 2]

See pricing